Extracellular histones inhibit efferocytosis

Molecular Medicine

Volumn 18, Issue 5, 2012, Pages 825-833

  Friggeri, Arnaud ^a,b,c   Banerjee, Sami ^a   Xie, Na ^a   Cui, Huachun ^a   de Freitas, Andressa ^a   Zerfaoui, Mourad ^a   Dupont, Hervé ^b,c   Abraham, Edward ^d   Liu, Gang ^a  

^a University of Alabama at Birmingham   (United States)

^b AMIENS UNIVERSITY HOSPITAL   (France)

^c INSERM   (France)

^d WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED PROTEIN C; ALPHAVBETA5 INTEGRIN; HISTONE H1; HISTONE H3; HISTONE H4;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BINDING AFFINITY; CELLULAR, SUBCELLULAR AND MOLECULAR BIOLOGICAL PHENOMENA AND FUNCTIONS; CONTROLLED STUDY; EFFEROCYTOSIS; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; MALE; MOUSE; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION;

ANIMALS; ANTIGENS, SURFACE; EXTRACELLULAR SPACE; HISTONES; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; KINETICS; MACROPHAGES; MALE; MICE; MICE, INBRED C57BL; MILK PROTEINS; OPSONIN PROTEINS; PHAGOCYTOSIS; PROTEIN BINDING; PROTEIN KINASE C; PROTO-ONCOGENE PROTEINS; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTORS, VITRONECTIN;

EID: 84867802641     PISSN: 10761551     EISSN: None     Source Type: Journal    
DOI: 10.2119/molmed.2012.00005     Document Type: Article

References (33)

1. Vandivier RW, Henson PM, Douglas IS. (2006) Burying the dead: the impact of failed apoptotic cell removal (efferocytosis) on chronic inflamma- tory lung disease. Chest. 129:1673-82.
2. Blasi F, Sidenius N. (2009) Efferocytosis: another function of uPAR. Blood. 114:752-3.
3. Armstrong A, Ravichandran KS. (2011) Phos- phatidylserine receptors: what is the new RAGE? EMBO Rep. 12:287-8.
4. Elliott MR, Ravichandran KS. (2010) Clearance of apoptotic cells: implications in health and dis- ease. J. Cell Biol. 189:1059-70.
5. Ravichandran KS. (2010) Find-me and eat-me signals in apoptotic cell clearance: progress and conundrums. J. Exp. Med. 207:1807-17.
6. Park D, et al. (2007) BAI1 is an engulfment recep- tor for apoptotic cells upstream of the ELMO/Dock180/Rac module. Nature. 450:430-4.
7. Miyanashi M, Tada K, Koike M, Uchiyama Y, Kitamura T, Nagata S. (2007) Identification of Tim4 as a phosphatidylserine receptor. Nature. 450:435-9.
8. He M, et al. (2011) Receptor for advanced glyca- tion end products binds to phosphatidylserine and assists in the clearance of apoptotic cells. EMBO Rep. 12:358-64.
9. Banerjee S, Friggeri A, Liu G, Abraham E. (2010) The C-terminal acidic tail is responsible for the inhibitory effects of HMGB1 on efferocytosis. J. Leukoc. Biol. 88:973-9.
10. Friggeri A, Y Yang, S Banerjee, Park YJ, Liu G, Abraham E. (2010) HMGB1 inhibits macrophage activity in efferocytosis through binding to the alphavbeta3-integrin. Am. J. Physiol. Cell Physiol. 299:C1267-76.
11. Liu G, et al. (2008) High mobility group protein-1 inhibits phagocytosis of apoptotic neutrophils through binding to phosphatidylserine. J. Im- munol. 181:4240-6.
12. Fuchs TA, et al. (2010) Extracellular DNA traps promote thrombosis. Proc. Natl. Acad. Sci. U. S. A. 107:15880-5.
13. Pemberton AD, Brown JK, Inglis NF. (2010) Pro- teomic identification of interactions between his- tones and plasma proteins: implications for cyto- protection. Proteomics. 10:1484-93.
14. Monach PA, et al. (2009) A broad screen for tar- gets of immune complexes decorating arthritic joints highlights deposition of nucleosomes in rheumatoid arthritis. Proc. Natl. Acad. Sci. U. S. A. 106:15867-72.
15. Papayannopoulos V, Zychlinsky A. (2009) NETs: a new strategy for using old weapons. Trends Im- munol. 30:513-21.
16. Neeli I, Dwivedi N, Khan S, Radic M. (2009) Reg- ulation of extracellular chromatin release from neutrophils. J. Innate Immun. 1:194-201.
17. Xu J, Zhang X, Monestier M, Esmon NL, Esmon CT. (2011) Extracellular histones are mediators of death through TLR2 and TLR4 in mouse fatal liver injury. J. Immunol. 187:2626-31.
18. Xu J, et al. (2009) Extracellular histones are major mediators of death in sepsis. Nat. Med. 15:1318-21.
19. Margraf S, et al. (2008) Neutrophil-derived circu- lating free DNA (cf-DNA/NETs): a potential prognostic marker for posttraumatic develop- ment of inflammatory second hit and sepsis. Shock. 30:352-8.
20. Friggeri A, et al. (2010) HMGB1 inhibits macro- phage activity in efferocytosis through binding to the alphavbeta3-integrin. Am. J. Physiol. Cell Physiol. 299:C1267-76.
21. Ravichandran KS. (2010) Find-me and eat-me signals in apoptotic cell clearance: progress and conundrums. J. Exp. Med. 207:1807-17.
22. Cui T, et al. (2010) Milk fat globule epidermal growth factor 8 attenuates acute lung injury in mice after intestinal ischemia and reperfusion. Am. J. Respir. Crit. Care Med. 181:238-46.
23. Yang Y, et al. (2010) Urokinase-type plasminogen activator inhibits efferocytosis of neutrophils. Am. J. Respir. Crit. Care Med. 182:1516-23.
24. Esmon CT. (2001) Role of coagulation inhibitors in inflammation. Thromb. Haemost. 86:51-6.
25. Abraham E. (2005) Effects of recombinant human activated protein C in human models of endo- toxin administration. Proc. Am. Thorac. Soc. 2:243-7.
26. Ely EW, et al. (2003) Drotrecogin alfa (activated) administration across clinically important sub- groups of patients with severe sepsis. Crit. Care Med. 31:12-9.
27. Bernard GR, et al. (2001) Efficacy and safety of recombinant human activated protein C for se- vere sepsis. N. Engl. J. Med. 344:699-709.
28. Husari AW, et al. (2010) Activated protein C attenuates acute lung injury and apoptosis in a hyperoxic animal model. Shock. 33:467-72.
29. Ruf W. (2010) New players in the sepsis- protective activated protein C pathway. J. Clin. Invest. 120:3084-7.
30. Kerschen E. (2010) Activated protein C targets CD8+ dendritic cells to reduce the mortality of endotoxemia in mice. J. Clin. Invest. 120:3167-78.
31. Cao C, et al. (2010) The efficacy of activated pro- tein C in murine endotoxemia is dependent on integrin CD11b. J. Clin. Invest. 120:1971-80.
32. Xu J, et al. (2009) Extracellular histones are major mediators of death in sepsis. Nat. Med. 15:1318-21.
33. Andersson U, Tracey KJ. (2011) HMGB1 is a ther- apeutic target for sterile inflammation and infec- tion. Annu. Rev. Immunol. 29:139-62.